- Home
- HAFC vs AQST Comparison
HAFC vs AQST Comparison
Compare HAFC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HAFC | AQST |
|---|---|---|
| Founded | 1982 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 758.9M | 707.6M |
| IPO Year | 1996 | 2018 |
Fundamental Metrics
Financial Performance| Metric | HAFC | AQST |
|---|---|---|
| Price | $25.03 | $3.24 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $28.50 | $8.83 |
| AVG Volume (30 Days) | 262.2K | ★ 6.3M |
| Earning Date | 01-27-2026 | 03-04-2026 |
| Dividend Yield | ★ 3.79% | N/A |
| EPS Growth | ★ 22.44 | N/A |
| EPS | ★ 2.51 | N/A |
| Revenue | ★ $255,726,000.00 | $43,397,000.00 |
| Revenue This Year | $19.61 | N/A |
| Revenue Next Year | $11.05 | $43.02 |
| P/E Ratio | $11.34 | ★ N/A |
| Revenue Growth | ★ 11.21 | N/A |
| 52 Week Low | $19.25 | $2.12 |
| 52 Week High | $30.20 | $7.55 |
Technical Indicators
Market Signals| Indicator | HAFC | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 30.19 | 26.63 |
| Support Level | $28.02 | $3.17 |
| Resistance Level | $30.20 | $3.55 |
| Average True Range (ATR) | 0.96 | 0.27 |
| MACD | -0.20 | -0.06 |
| Stochastic Oscillator | 9.45 | 2.54 |
Price Performance
Historical ComparisonAbout HAFC Hanmi Financial Corporation
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.